AMRI Global

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AMRI Global and buy or sell other stocks, ETFs, and their options commission-free!

About AMRI

Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. 

CEO
Philip W. Macnabb, MBA
CEOPhilip W. Macnabb, MBA
Employees
Employees
Headquarters
Albany, New York
HeadquartersAlbany, New York
Founded
1991
Founded1991
Employees
Employees

AMRI Key Statistics

Market cap
934.02M
Market cap934.02M
Price-Earnings ratio
-15.32
Price-Earnings ratio-15.32
Dividend yield
Dividend yield
Average volume
999.91K
Average volume999.91K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$22.17
52 Week high$22.17
52 Week low
$13.01
52 Week low$13.01

Stock Snapshot

As of today, AMRI Global(AMRI) shares are valued at $21.74. The company's market cap stands at 934.02M, with a P/E ratio of -15.32.

During the trading day, AMRI Global(AMRI) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 999.91K.

Over the past 52 weeks, AMRI Global(AMRI) stock has traded between a high of $22.17 and a low of $13.01.

Over the past 52 weeks, AMRI Global(AMRI) stock has traded between a high of $22.17 and a low of $13.01.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.